Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Ciprofloxacin

A broad-spectrum fluoroquinolone antibiotic that blocks the bacterial enzymes DNA gyrase and topoisomerase IV, patented in 1980 and on the market since 1987: it is on the WHO List of Essential Medicines. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?Its family began with a by-product: the first quinolone, nalidixic acid, was isolated during the synthesis of the antimalarial chloroquine and introduced in the 1960s.

CiprofloxacinGo to the active ingredient →
CiprofloxacinActive ingredientCiprofloxacinCat. No. P-C173-001CAS 85721-33-1

EDQM standards 4

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.